Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Neutrophilic, Chronic × Amplified Fragment Length Polymorphism Analysis × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 6 Lymphoma, Follicular 4 Lymphoma 4 Prostatic Neoplasms 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Large-Cell, Anaplastic 3 Lymphoma, Extranodal NK-T-Cell 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Hodgkin Disease 3 Congenital Abnormalities 3 Burkitt Lymphoma 3 Waldenstrom Macroglobulinemia 2 Sezary Syndrome 2 Rectal Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Myeloproliferative Disorders 2 Myelodysplastic Syndromes 2 Mycosis Fungoides 2 Multiple Myeloma 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myeloid, Acute 2 Leukemia, Myeloid, Accelerated Phase 2 Immunoblastic Lymphadenopathy 2 Colorectal Neoplasms 2 Colonic Neoplasms 2

Interventions

fludarabine phosphate 10 Cyclophosphamide 8 Busulfan 8 Whole-Body Irradiation 7 Peripheral Blood Stem Cell Transplantation 7 Mycophenolic Acid 7 Antilymphocyte Serum 7 Tacrolimus 6 Methotrexate 5 Cyclosporine 5 thymoglobulin 4 Melphalan 4 Rituximab 3 Radiotherapy 3 Etoposide 3 Cord Blood Stem Cell Transplantation 3 Sirolimus 2 Ondansetron 2 Granulocyte Colony-Stimulating Factor 2 Dexamethasone 2 Cytarabine 2 Carmustine 2 Calcium Dobesilate 2 Aprepitant 2 ruxolitinib 1 fludarabine 1 fedratinib 1 etoposide phosphate 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡